Zymergi LogoCart

483 Document: Apertus Pharmaceuticals, Jan 16, 2020

FDANews 483 Apertus Pharmaceuticals Jan 16 2020 top
Robert J. Ham FDA Investigator Michele Perry-Williams FDA Investigator Ana Paula Sandee FDA Investigator Sandee, Ana Paula P FDA Investigator

On Jan 16, 2020, the FDA inspected Apertus Pharmaceuticals's Ballwin site. Explore the inspectional observations.